On the public citation graph
Safety and Immunogenicity of Adenovirus-Vectored Near-Consensus HIV Type 1 Clade B gag Vaccines in Healthy Adults
0 signed · 94 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1016/s0140-6736(08)61591-3openalex-snapshot
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial
inferredcites →https://doi.org/10.1016/s0140-6736(08)61592-5openalex-snapshot
HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case–cohort analysis
inferredcites →https://doi.org/10.1038/345622a0openalex-snapshot
Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160
inferredcites →https://doi.org/10.1038/415331aopenalex-snapshot
Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity
inferredcites →https://doi.org/10.1038/nature01188openalex-snapshot
HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites
inferredcites →https://doi.org/10.1056/nejmra066267openalex-snapshot
An HIV Vaccine — Evolving Concepts
inferredcites →https://doi.org/10.1056/nejmra0706737openalex-snapshot
The Challenge of HIV-1 Subtype Diversity
inferredcites →https://doi.org/10.1084/jem.189.6.991openalex-snapshot
Dramatic Rise in Plasma Viremia after CD8+ T Cell Depletion in Simian Immunodeficiency Virus–infected Macaques
inferredcites →https://doi.org/10.1086/428404openalex-snapshot
Placebo‐Controlled Phase 3 Trial of a Recombinant Glycoprotein 120 Vaccine to Prevent HIV‐1 Infection
inferredcites →https://doi.org/10.1086/428450openalex-snapshot
Cross‐Reactivity of Anti–HIV‐1 T Cell Immune Responses among the Major HIV‐1 Clades in HIV‐1–Positive Individuals from 4 Continents
inferredcites →https://doi.org/10.1086/505979openalex-snapshot
HIV Vaccines: New Frontiers in Vaccine Development
inferredcites →https://doi.org/10.1086/508749openalex-snapshot
Prevalence of Primary HIV‐1 Drug Resistance among Recently Infected Adolescents: A Multicenter Adolescent Medicine Trials Network for HIV/AIDS Interventions Study
inferredcites →https://doi.org/10.1086/512371openalex-snapshot
HIV Epidemiology Update and Transmission Factors: Risks and Risk Contexts--16th International AIDS Conference Epidemiology Plenary
inferredcites →https://doi.org/10.1086/587993openalex-snapshot
Safety and Immunogenicity of a Replication‐Incompetent Adenovirus Type 5 HIV‐1 Clade B gag/pol/nef Vaccine in Healthy Adults
inferredcites →https://doi.org/10.1089/10430340360464688openalex-snapshot
Development of an Adenovirus-Shedding Assay for the Detection of Adenoviral Vector-Based Vaccine and Gene Therapy Products in Clinical Specimens
inferredcites →https://doi.org/10.1089/104303403766682278openalex-snapshot
Comparative Analysis of the Effects of Packaging Signal, Transgene Orientation, Promoters, Polyadenylation Signals, and E3 Region on Growth Properties of First-Generation Adenoviruses
inferredcites →https://doi.org/10.1089/104303404322886147openalex-snapshot
Quantitative Adenovirus Neutralization Assays Based on the Secreted Alkaline Phosphatase Reporter Gene: Application in Epidemiologic Studies and in the Design of Adenovector Vaccines
inferredcites →https://doi.org/10.1089/aid.1996.12.585openalex-snapshot
Strong Cytotoxic T Cell and Weak Neutralizing Antibody Responses in a Subset of Persons with Stable Nonprogressing HIV Type 1 Infection
inferredcites →https://doi.org/10.1089/aid.2006.0114openalex-snapshot
Evaluation of Cellular Immune Responses in Subjects Chronically Infected with HIV Type 1
inferredcites →https://doi.org/10.1097/01.aids.0000131310.52526.c7openalex-snapshot
The prevalence of antiretroviral drug resistance in the United States
inferredcites →https://doi.org/10.1097/01.aids.0000252059.85236.afopenalex-snapshot
Routine surveillance for the detection of acute and recent HIV infections and transmission of antiretroviral resistance
inferredcites →https://doi.org/10.1097/qai.0b013e3180377b5bopenalex-snapshot
Detection of HIV Vaccine-Induced Cell-Mediated Immunity in HIV-Seronegative Clinical Trial Participants Using an Optimized and Validated Enzyme-Linked Immunospot Assay
inferredcites →https://doi.org/10.1126/science.283.5403.857openalex-snapshot
Control of Viremia in Simian Immunodeficiency Virus Infection by CD8 + Lymphocytes
inferredcites →https://doi.org/10.1128/jvi.72.1.164-169.1998openalex-snapshot
Administration of an Anti-CD8 Monoclonal Antibody Interferes with the Clearance of Chimeric Simian/Human Immunodeficiency Virus during Primary Infections of Rhesus Macaques
inferredcites →https://doi.org/10.1128/jvi.77.11.6305-6313.2003openalex-snapshot
Comparative Immunogenicity in Rhesus Monkeys of DNA Plasmid, Recombinant Vaccinia Virus, and Replication-Defective Adenovirus Vectors Expressing a Human Immunodeficiency Virus Type 1 gag Gene
inferredcites →https://doi.org/10.1128/jvi.77.13.7663-7668.2003openalex-snapshot
Vaccine-Induced Immunity in Baboons by Using DNA and Replication-Incompetent Adenovirus Type 5 Vectors Expressing a Human Immunodeficiency Virus Type 1 gag Gene
inferredcites →https://doi.org/10.1177/135965350100600108openalex-snapshot
Resistance Profiles to Antiretroviral Drugs in HIV-1 Drug-Naive Patients in Argentina
inferredcites →https://doi.org/10.1177/135965350601100208openalex-snapshot
Evolution of Transmitted HIV-1 with Drug-Resistance Mutations in the Absence of Therapy: Effects on Cd4 + T-Cell Count and HIV-1 Rna Load
inferredcites →https://doi.org/10.1177/135965350601100503openalex-snapshot
Drug-Class-Wide Resistance to Antiretrovirals in HIV-Infected Patients Failing Therapy: Prevalence, Risk Factors and Virological Outcome
inferredcites →https://doi.org/10.1191/0962280204sm363raopenalex-snapshot
Use of the false discovery rate for evaluating clinical safety data
inferredcites →https://doi.org/10.2307/2530666openalex-snapshot
Testing the Statistical Certainty of a Response to Increasing Doses of a Drug
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4669153openalex-extracted
A Phase 1b Clinical Trial to Determine the Safety, Tolerability and Immunogenicity of the Candidate Mycobacterium Avium Complex Subspecies Vaccines ChAdOx2 HAV and MVA HAV in Patients with Active Crohn's Disease
inferred← citeshttps://doi.org/10.1002/eji.200839130openalex-snapshot
Adenovirus 5‐ and 35‐based immunotherapy enhances the strength but not breadth or quality of immunity during chronic SIV infection
inferred← citeshttps://doi.org/10.1002/jcb.22328openalex-snapshot
The influence of innate and pre‐existing immunity on adenovirus therapy
inferred← citeshttps://doi.org/10.1002/jmv.23325openalex-snapshot
Seroprevalence of neutralizing antibodies to human adenovirus type 5 in healthy adults in China
inferred← citeshttps://doi.org/10.1002/rmv.625openalex-snapshot
HIV‐1 vaccine clinical trials: the Brazilian experience
inferred← citeshttps://doi.org/10.1007/s00705-015-2333-2openalex-snapshot
The sero-prevalence of anti-adenovirus 5 neutralizing antibodies is independent of a chronic hepatitis B carrier state in China
inferred← citeshttps://doi.org/10.1007/s11908-009-0056-9openalex-snapshot
Advances in human clinical trials of vaccines to prevent HIV/AIDS and other HIV prevention interventions
inferred← citeshttps://doi.org/10.1016/b978-0-12-415847-4.00066-5openalex-snapshot
Filling the Immunological Gap
inferred← citeshttps://doi.org/10.1016/b978-0-12-800276-6.00015-2openalex-snapshot
Antibodies against Adenoviruses
inferred← citeshttps://doi.org/10.1016/b978-0-12-800276-6.00021-8openalex-snapshot
Adenoviral Vector Vaccines Antigen Transgene
inferred← citeshttps://doi.org/10.1016/b978-0-323-35761-6.00067-5openalex-snapshot
Development of Gene-Based Vectors for Immunization
inferred← citeshttps://doi.org/10.1016/b978-1-4557-0090-5.00064-1openalex-snapshot
The development of gene-based vectors for immunization
inferred← citeshttps://doi.org/10.1016/bs.ircmb.2018.07.006openalex-snapshot
T Lymphocytes as Measurable Targets of Protection and Vaccination Against Viral Disorders
inferred← citeshttps://doi.org/10.1016/j.antiviral.2024.105823openalex-snapshot
Unmasking the potential of secretory IgA and its pivotal role in protection from respiratory viruses
inferred← citeshttps://doi.org/10.1016/j.immuni.2010.10.004openalex-snapshot
Immunologic Basis of Vaccine Vectors
inferred← citeshttps://doi.org/10.1016/j.vaccine.2009.10.111openalex-snapshot
Comparative performance of a licensed anthrax vaccine versus electroporation based delivery of a PA encoding DNA vaccine in rhesus macaques
inferred← citeshttps://doi.org/10.1016/j.vaccine.2009.10.145openalex-snapshot
International epidemiology of human pre-existing adenovirus (Ad) type-5, type-6, type-26 and type-36 neutralizing antibodies: Correlates of high Ad5 titers and implications for potential HIV vaccine trials
inferred← citeshttps://doi.org/10.1016/j.vaccine.2010.08.077openalex-snapshot
Vaccination with a modified vaccinia virus Ankara (MVA)-vectored HIV-1 immunogen induces modest vector-specific T cell responses in human subjects
inferred← citeshttps://doi.org/10.1016/j.vaccine.2010.09.079openalex-snapshot
Comparison of T cell immune responses induced by vectored HIV vaccines in non-human primates and humans
inferred← citeshttps://doi.org/10.1016/j.vaccine.2010.12.058openalex-snapshot
The PEDVAC trial: Preliminary data from the first therapeutic DNA vaccination in HIV-infected children
inferred← citeshttps://doi.org/10.1016/j.vaccine.2011.06.085openalex-snapshot
Human immunodeficiency virus (HIV) immunopathogenesis and vaccine development: A review
inferred← citeshttps://doi.org/10.1016/j.vaccine.2018.02.075openalex-snapshot
Evaluation of adenovirus 19a as a novel vector for mucosal vaccination against influenza A viruses
inferred← citeshttps://doi.org/10.1016/j.virol.2013.12.029openalex-snapshot
Protection of non-human primates against rabies with an adenovirus recombinant vaccine
inferred← citeshttps://doi.org/10.1016/j.virusres.2015.09.010openalex-snapshot
Immunogenicity and efficacy in mice of an adenovirus-based bicistronic rotavirus vaccine expressing NSP4 and VP7
inferred← citeshttps://doi.org/10.1016/s1473-3099(14)70020-9openalex-snapshot
Recombinant adenovirus type 5 HIV gag/pol/nef vaccine in South Africa: unblinded, long-term follow-up of the phase 2b HVTN 503/Phambili study
inferred← citeshttps://doi.org/10.1038/s41598-026-60421-0openalex-snapshot
IRO-203: a novel intranasal COVID-19 vaccine showing immunogenicity and viral suppression in African green monkey challenge study
inferred← citeshttps://doi.org/10.1080/10601330903012436openalex-snapshot
Approaches and issues towards development of efficient mucosal vaccines against pneumonia
inferred← citeshttps://doi.org/10.1086/648591openalex-snapshot
Comparative Cell‐Mediated Immunogenicity of DNA/DNA, DNA/Adenovirus Type 5 (Ad5), or Ad5/Ad5 HIV‐1 Clade BgagVaccine Prime‐Boost Regimens
inferred← citeshttps://doi.org/10.1086/655468openalex-snapshot
AIDS Clinical Trials Group 5197: A Placebo‐Controlled Trial of Immunization of HIV‐1–Infected Persons with a Replication‐Deficient Adenovirus Type 5 Vaccine Expressing the HIV‐1 Core Protein
inferred← citeshttps://doi.org/10.1089/aid.2010.0151openalex-snapshot
Safety and Immunogenicity of the MRKAd5 gag HIV Type 1 Vaccine in a Worldwide Phase 1 Study of Healthy Adults
inferred← citeshttps://doi.org/10.1093/infdis/jis670openalex-snapshot
First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Adenovirus Serotype 26 HIV-1 Env Vaccine (IPCAVD 001)
inferred← citeshttps://doi.org/10.1101/cshperspect.a007351openalex-snapshot
Human Immunodeficiency Virus Vaccine Trials
inferred← citeshttps://doi.org/10.1111/hiv.70024openalex-snapshot
mRNA vaccines against HIV : Hopes and challenges
inferred← citeshttps://doi.org/10.1111/j.1600-065x.2010.00980.xopenalex-snapshot
DNA vaccines: an historical perspective and view to the future
inferred← citeshttps://doi.org/10.1126/scitranslmed.3006843openalex-snapshot
A Human Type 5 Adenovirus–Based Tuberculosis Vaccine Induces Robust T Cell Responses in Humans Despite Preexisting Anti-Adenovirus Immunity
inferred← citeshttps://doi.org/10.1128/cvi.00144-09openalex-snapshot
Safety and Immunogenicity of the Merck Adenovirus Serotype 5 (MRKAd5) and MRKAd6 Human Immunodeficiency Virus Type 1 Trigene Vaccines Alone and in Combination in Healthy Adults
inferred← citeshttps://doi.org/10.1128/jvi.00788-11openalex-snapshot
DNA/NYVAC Vaccine Regimen Induces HIV-Specific CD4 and CD8 T-Cell Responses in Intestinal Mucosa
inferred← citeshttps://doi.org/10.1155/2018/8521060openalex-snapshot
A Multiagent Alphavirus DNA Vaccine Delivered by Intramuscular Electroporation Elicits Robust and Durable Virus-Specific Immune Responses in Mice and Rabbits and Completely Protects Mice against Lethal Venezuelan, Western, and Eastern Equine Encephalitis Virus Aerosol Challenges
inferred← citeshttps://doi.org/10.1164/rccm.200910-1484ocopenalex-snapshot
The Novel Tuberculosis Vaccine, AERAS-402, Induces Robust and Polyfunctional CD4+ and CD8+ T Cells in Adults
inferred← citeshttps://doi.org/10.1189/jlb.1a0813-451rropenalex-snapshot
The effect of adenovirus-specific antibodies on adenoviral vector–induced, transgene product–specific T cell responses
inferred← citeshttps://doi.org/10.1371/journal.pntd.0000515openalex-snapshot
Novel Vaccines to Human Rabies
inferred← citeshttps://doi.org/10.1371/journal.pone.0010818openalex-snapshot
Preferential Amplification of CD8 Effector-T Cells after Transcutaneous Application of an Inactivated Influenza Vaccine: A Randomized Phase I Trial
inferred← citeshttps://doi.org/10.1371/journal.pone.0013579openalex-snapshot
Safety and Immunogenicity of a Replication-Defective Adenovirus Type 5 HIV Vaccine in Ad5-Seronegative Persons: A Randomized Clinical Trial (HVTN 054)
inferred← citeshttps://doi.org/10.1371/journal.pone.0014385openalex-snapshot
Vaccination with Ad5 Vectors Expands Ad5-Specific CD8+ T Cells without Altering Memory Phenotype or Functionality
inferred← citeshttps://doi.org/10.1371/journal.pone.0024586openalex-snapshot
Adenovirus 5-Vectored P. falciparum Vaccine Expressing CSP and AMA1. Part A: Safety and Immunogenicity in Seronegative Adults
inferred← citeshttps://doi.org/10.1371/journal.pone.0025868openalex-snapshot
Adenovirus-5-Vectored P. falciparum Vaccine Expressing CSP and AMA1. Part B: Safety, Immunogenicity and Protective Efficacy of the CSP Component
inferred← citeshttps://doi.org/10.1371/journal.pone.0062720openalex-snapshot
Consensus HIV-1 FSU-A Integrase Gene Variants Electroporated into Mice Induce Polyfunctional Antigen-Specific CD4+ and CD8+ T Cells
inferred← citeshttps://doi.org/10.1371/journal.pone.0106241openalex-snapshot
Sterile Immunity to Malaria after DNA Prime/Adenovirus Boost Immunization Is Associated with Effector Memory CD8+T Cells Targeting AMA1 Class I Epitopes
inferred← citeshttps://doi.org/10.1371/journal.pone.0136626openalex-snapshot
Effect of rAd5-Vector HIV-1 Preventive Vaccines on HIV-1 Acquisition: A Participant-Level Meta-Analysis of Randomized Trials
inferred← citeshttps://doi.org/10.1371/journal.pone.0137666openalex-snapshot
Continued Follow-Up of Phambili Phase 2b Randomized HIV-1 Vaccine Trial Participants Supports Increased HIV-1 Acquisition among Vaccinated Men
inferred← citeshttps://doi.org/10.1586/erv.10.106openalex-snapshot
Prime–boost immunization with poxvirus or adenovirus vectors as a strategy to develop a protective vaccine for HIV-1
inferred← citeshttps://doi.org/10.1586/erv.11.88openalex-snapshot
Optimizing vaccine-induced CD8+T-cell immunity: focus on recombinant adenovirus vectors
inferred← citeshttps://doi.org/10.3389/fimmu.2018.00335openalex-snapshot
Seroprevalence of Neutralizing Antibodies against Human Adenovirus Type-5 and Chimpanzee Adenovirus Type-68 in Cancer Patients
inferred← citeshttps://doi.org/10.3390/cancers15010238openalex-snapshot
HIV-1 Protease as DNA Immunogen against Drug Resistance in HIV-1 Infection: DNA Immunization with Drug Resistant HIV-1 Protease Protects Mice from Challenge with Protease-Expressing Cells
inferred← citeshttps://doi.org/10.3390/v13071221openalex-snapshot
Understanding Post Entry Sorting of Adenovirus Capsids; A Chance to Change Vaccine Vector Properties
inferred← citeshttps://doi.org/10.3390/vaccines11040784openalex-snapshot
Immunogenicity Differences of the ChAdOx1 nCoV-19 Vaccine According to Pre-Existing Adenovirus Immunity
inferred← citeshttps://doi.org/10.3390/vaccines7020040openalex-snapshot
Safety and Immunogenicity of a Novel Recombinant Simian Adenovirus ChAdOx2 as a Vectored Vaccine
inferred← citeshttps://doi.org/10.35772/ghm.2021.01010openalex-snapshot
COVID-19 vaccines: implementation, limitations and opportunities
inferred← citeshttps://doi.org/10.4161/hv.21408openalex-snapshot
Adaptation of a previously validated vaccination report card for use in adult vaccine clinical trials to align with the 2007 FDA Toxicity Grading Scale Guidance
inferred← citeshttps://doi.org/10.4161/hv.24941openalex-snapshot
Human adenovirus 5-vectoredPlasmodium falciparumNMRC-M3V-Ad-PfCA vaccine encoding CSP and AMA1 is safe, well-tolerated and immunogenic but does not protect against controlled human malaria infection
inferred← citeshttps://doi.org/10.4172/2155-6113.1000293openalex-snapshot
Is Prime Boost Strategy a Promising Approach in HIV Vaccine Development?
inferred← citeshttps://doi.org/10.70675/c649b442z5a71z428dz9356z2a8d03796760openalex-snapshot
Élaboration d'Intrabodies ciblant l'organisation conformationnelle du complexe de reverse transcription de VIH-1
inferred← citeshttps://doi.org/10.70675/f8627351ze846z41b4zbb53zfbeef2b2e76dopenalex-snapshot
Conception de nouveaux vaccins anti-VIH basés sur des épitopes conformationels cross clade de gp41 issus d'anticorps muqueux protecteurs de sujets exposés au VIH mais restant séronégatifs (ESN)
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.